Joel Raffel

625 total citations
17 papers, 313 citations indexed

About

Joel Raffel is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Joel Raffel has authored 17 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 5 papers in Rheumatology and 4 papers in Neurology. Recurrent topics in Joel Raffel's work include Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (4 papers) and Polyomavirus and related diseases (4 papers). Joel Raffel is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (4 papers) and Polyomavirus and related diseases (4 papers). Joel Raffel collaborates with scholars based in United Kingdom, Germany and Netherlands. Joel Raffel's co-authors include Richard Nicholas, Omar Malik, Rolf Sprengel, Ole Paulsen, Carola Romberg, David M. Bannerman, J. N. P. Rawlins, Peter H. Seeburg, Tim Friede and Roger N. Gunn and has published in prestigious journals such as PLoS ONE, Neurology and PLoS Medicine.

In The Last Decade

Joel Raffel

17 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel Raffel United Kingdom	11	110	70	65	63	48	17	313
Noemi Pasquarelli Germany	10	114 1.0×	55 0.8×	104 1.6×	61 1.0×	28 0.6×	18	420
A. Garcı́a-Merino Spain	11	156 1.4×	49 0.7×	82 1.3×	114 1.8×	38 0.8×	18	480
Rhusheet Patel United States	7	135 1.2×	40 0.6×	78 1.2×	51 0.8×	71 1.5×	15	367
М. Н. Захарова Russia	8	124 1.1×	28 0.4×	75 1.2×	38 0.6×	83 1.7×	106	328
Junjie Wei China	8	56 0.5×	33 0.5×	69 1.1×	25 0.4×	60 1.3×	20	301
Cathy Jensen Belgium	9	52 0.5×	23 0.3×	105 1.6×	68 1.1×	102 2.1×	11	363
Petra Lelková Czechia	8	132 1.2×	35 0.5×	105 1.6×	16 0.3×	31 0.6×	9	341
Jinsong Jiao China	11	47 0.4×	30 0.4×	163 2.5×	28 0.4×	26 0.5×	30	457
C. T. Bever United States	6	305 2.8×	48 0.7×	66 1.0×	43 0.7×	43 0.9×	6	414
Shinsuke Hamada Japan	13	39 0.4×	27 0.4×	107 1.6×	93 1.5×	32 0.7×	46	467

Countries citing papers authored by Joel Raffel

Since Specialization

Citations

This map shows the geographic impact of Joel Raffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Raffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Raffel more than expected).

Fields of papers citing papers by Joel Raffel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Raffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Raffel. The network helps show where Joel Raffel may publish in the future.

Co-authorship network of co-authors of Joel Raffel

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Raffel. A scholar is included among the top collaborators of Joel Raffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Raffel. Joel Raffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Raffel, Joel, Christopher J. Record, David J. Brooks, et al.. (2019). Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Molecular Imaging and Biology. 21(5). 935–944. 16 indexed citations

Nicholas, Richard, et al.. (2018). Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials. Multiple Sclerosis Journal. 25(11). 1462–1471. 5 indexed citations

Raffel, Joel, Alison E. Wallace, Djordje Gverić, et al.. (2017). Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29. PLoS Medicine. 14(7). e1002346–e1002346. 17 indexed citations

Raffel, Joel, et al.. (2017). Brain Age: A novel approach to quantify the impact of multiple sclerosis on the brain (P1.371). Neurology. 88(16_supplement). 3 indexed citations

Raffel, Joel, et al.. (2017). Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis. PLoS ONE. 12(1). e0169546–e0169546. 4 indexed citations

Raffel, Joel, et al.. (2017). Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis. Drugs. 77(8). 885–910. 15 indexed citations

Kamourieh, Salwa, et al.. (2017). Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF. Neurology Neuroimmunology & Neuroinflammation. 4(5). e384–e384. 3 indexed citations

Puentes, Fabìola, Stephanie D. Boomkamp, Markus Kipp, et al.. (2017). Neurofilament light as an immune target for pathogenic antibodies. Immunology. 152(4). 580–588. 10 indexed citations

Feeney, Claire, Gregory Scott, Joel Raffel, et al.. (2016). Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. 43(12). 2201–2210. 56 indexed citations

10.

Martin, Jessica, Joel Raffel, & Richard Nicholas. (2016). Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care. PLoS ONE. 11(7). e0159210–e0159210. 8 indexed citations

11.

Raffel, Joel, Benjamin R. Wakerley, & Richard Nicholas. (2016). Multiple sclerosis. Medicine. 44(9). 537–541. 17 indexed citations

12.

Raffel, Joel, et al.. (2015). Anti-JC virus antibody titres increase over time with natalizumab treatment. Multiple Sclerosis Journal. 21(14). 1833–1838. 36 indexed citations

13.

Raffel, Joel, Ruth Dobson, Arie Gafson, et al.. (2014). Multiple sclerosis therapy and Epstein–Barr virus antibody titres. Multiple Sclerosis and Related Disorders. 3(3). 372–374. 15 indexed citations

14.

Amor, Sandra, Isabel Boscá, Joel Raffel, et al.. (2014). Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis. Multiple Sclerosis Journal. 20(10). 1355–1362. 30 indexed citations

15.

Sharrief, Anjail, Joel Raffel, & David S. Zee. (2012). Vitamin B₁₂Deficiency With Bilateral Globus Pallidus Abnormalities. Archives of Neurology. 69(6). 769–772. 15 indexed citations

16.

Raffel, Joel, et al.. (2011). Rash and dyspnoea in a 39 year old man. BMJ. 343(dec29 1). d8256–d8256. 1 indexed citations

17.

Romberg, Carola, Joel Raffel, Rolf Sprengel, et al.. (2009). Induction and expression of GluA1 (GluR‐A)‐independent LTP in the hippocampus. European Journal of Neuroscience. 29(6). 1141–1152. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact